Skip to main content

Year: 2021

Fixing of coupon rates effective from 1 January 2022 – Nykredit Realkredit A/S

To Nasdaq Copenhagen 23 December 2021 FIXING OF COUPON RATES         Fixing of coupon rates effective from 1 January 2022 Effective from 1 January 2022, the coupon rates of floating-rate bonds issued by Nykredit Realkredit A/S will be adjusted. Bonds with semi-annual interest rate fixingThe new coupon rates will apply from 1 January 2022 to 30 June 2022: Uncapped bondsDK0009508319, (32G), maturity in 2022, new rate as at 1 January 2022: -0.1926% paDK0009520017, (32H), maturity in 2023, new rate as at 1 January 2022: -0.1825% paDK0009521338, (32G), maturity in 2023, new rate as at 1 January 2022: -0.1724% pa Bonds with quarterly interest rate fixingThe new coupon rates will apply from 1 January 2022 to 31 March 2022: Uncapped bondsDK0009512428, (22H), maturity in 2023, new rate as at 1 January 2022: 0.0620% paDK0009516411, (32H), maturity...

Continue reading

Monarch First Mining Company to Earn the Concilivi Seal

In recognition of the Corporation’s commitment to fostering work/life balance MONTREAL, Dec. 23, 2021 (GLOBE NEWSWIRE) — MONARCH MINING CORPORATION (“Monarch” or the “Corporation”) (TSX: GBAR) (OTCQX: GBARF) is pleased to announce that it has completed the accreditation process and been officially granted the Concilivi Seal by the Concilivi decision committee, for its work-life balance (“WLB”) best practices. Monarch, a supportive organizationMonarch launched the process of obtaining the Concilivi Seal in September 2021. Over the past few months, the Corporation has developed a workforce profile and consulted its employees with a view to developing a charter of new and enhanced measures for ensuring work-life balance. Meeting its employees’ real needs is a must for Monarch, and obtaining the Concilivi Seal was key to retaining...

Continue reading

US Energy Initiatives Deposits Digital Assets for Sale and Moves Into the Metaverse

WOODLAND HILLS, CA, Dec. 23, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — US Energy Initiatives Corp, Inc. (OTC PINK:USEI) announces that the Company has transferred $10 million of its digital assets to BMCS SUMCOIN INDEX FUND dba Bio Tech Medics, Inc. (stock symbol BMCS-OTC)  to be sold at “market value’ to generate capital to execute its 2022 Business Plan that includes “green energy mining” and the entrance into the Metaverse sector. According to Anthony K. Miller, CEO, “Today we announce that the Company has done what it reported in its December 14, 2021 press release, transferring $10 million dollars of its digital asset into position to be sold. Management hopes that the currency should be sold in the first few months of 2022. The BMCS business plan is designed to provide worldwide holders with an exit strategy...

Continue reading

Microbix Reports Record Results for Fiscal 2021

Record Sales of $18.6 million, Record Net Earnings of $3.2 million MISSISSAUGA, Ontario, Dec. 23, 2021 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, reports results for its year and fourth quarter ended September 30, 2021 (“2021” and “Q4”), with record sales and earnings, plus progress upon its strategic goal of increasing the proportion of revenues derived from medical devices. Management Discussion 2021 revenues were up 77% from 2020, achieving a record level of $18.6 million as Microbix continues to emphasize operational excellence and the sale of innovative, proprietary, and branded medical devices. Sales of test quality assessment products (“QAPs™”) for 2021 increased 208% from fiscal 2020. Microbix’s new product line, viral transport medium (branded...

Continue reading

Nubeva Announces Third-Party Validation Of Its Upcoming Ransomware Reversal Solution

Extended Third-Party Testing Confirms Software is Effective For 96% of Ransomware Tested SAN JOSE, Calif., Dec. 23, 2021 (GLOBE NEWSWIRE) — Nubeva Technologies (TSX-V: NBVA, OTC: NBVAF), a developer of B2B ransomware and network decryption software solutions, announces today positive results from third-party testing on new Ransomware Reversal technology. The findings validate previous claims that Nubeva can intercept encryption keys and decrypt (reverse) ransomware 96.84% of the time. Over four weeks, tests were conducted against thousands of random ransomware samples never seen by Nubeva. The samples came from both active and legacy families of malicious software, including Conti, Lockbit, Pysa, Haron, AvosLocker. The test group included cybersecurity manufacturers, managed security service providers, and end-users. “This is big...

Continue reading

Kaixin Auto Holdings Announces Framework Agreement for Order of 10,000 Customized Electric Trucks

BEIJING, Dec. 23, 2021 (GLOBE NEWSWIRE) — Kaixin Auto Holdings (“Kaixin” or the “Company”) (NASDAQ: KXIN) announces today that it has reached a strategic partnership agreement with Beijing Shencheng Biotechnology Group Limited (“Shencheng”). Under the framework agreement, Shencheng agrees to purchase 10,000 customized new energy trucks from Kaixin over the next 5 years. The total value is around $250 million. Shencheng is a well-known biotechnology company engaged in waste sorting and recycling in China. It plans to cooperate with local governments to implement waste disposal and resource reuse integration projects across China. Shencheng expects to purchase a large number of customized new energy trucks for its environmental protection and resource recycling projects in the next five years. Mr. Mingjun Lin, Chairman and CEO of...

Continue reading

P10 Announces $250MM Debt Refinancing

DALLAS, Dec. 23, 2021 (GLOBE NEWSWIRE) — P10, Inc. (NYSE: PX), a leading private markets solutions provider, today announced that it and certain of its subsidiaries, as guarantors, have entered into a $250 million credit facility with a syndicate of banks led by JPMorgan Chase Bank, N.A. and Texas Capital Bank. The new credit facility provides for a term loan in the amount of $125 million and a revolving commitment in the amount of $125 million. The company will use the loan proceeds to pay off the outstanding borrowings under its existing credit facility, pay off seller’s notes related to the RCP acquisition, and pay transaction-related expenses, as well as for working capital and other general corporate purposes. “The new credit facility led by JPMorgan Chase Bank, N.A. and Texas Capital Bank reflects P10’s strong operating model...

Continue reading

Cyclacel Pharmaceuticals to Participate in Biotech Showcase 2022 Virtual Conference

BERKELEY HEIGHTS, N.J., Dec. 23, 2021 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced that the Company will participate in the Biotech Showcase 2022 Virtual Conference to be held January 10-12, 2022. Spiro Rombotis, President & Chief Executive Officer, will present an overview of Cyclacel’s business and the Company will be available for virtual meetings during the conference. In addition, Mr. Rombotis will participate in a Biotech Showcase Workshop, entitled, “Outsmarting Cancer: Next Generation Therapies”. Details can be found below:  Conference: virtual meetings and on-demand presentation (available January 3, 2022)  Date: January...

Continue reading

IBEX Announces Stock Option Grant to Directors and Employees

MONTREAL, Dec. 23, 2021 (GLOBE NEWSWIRE) — IBEX Technologies Inc. (TSX Venture: IBT), today announced that on December 22, 2021 the Company’s Board of Directors granted stock options representing a total of 450,000 common shares to its directors and an officer of the Company. These options were granted at an exercise price of $0.48, being the closing price on December 21, 2021, and will expire on December 22, 2031. All options were granted pursuant to the IBEX Stock Option Plan. IBEX also announces that its Board of Directors on December 3, 2921 approved a resolution to reload the number of shares that can be issued under its Incentive Stock Option Plan to 2,400,000 shares, equal to approximately 9.7% of IBEX’s 24,823,244 issued and outstanding shares. The amendment to the Incentive Stock Option Plan is subject to approval of shareholders...

Continue reading

Resolutions of the Extraordinary General Meeting of Enedo Plc and signing of a Eur 5.0 million loan agreement

Enedo Plc         Stock Exchange Release         December 23, 2021 at 13:30 Resolutions of the Extraordinary General Meeting of Enedo Plc and signing of a Eur 5.0 million loan agreement The Extraordinary General Meeting of Enedo Plc (the “Company”) was held today 23 December 2021 at 10 a.m. in Vantaa. The Extraordinary General Meeting decided according to the Board of Directors proposal to authorize the Board of Directors to decide on a directed share issue for Inission Ab for a maximum amount of 55.000.000 new shares at a subscription price of Eur 0,10 cent per share. The directed share issue can only take place if Inission Ab becomes liable for the loan (including interests and expenses) on the basis of the guarantee liability and the Enedo Oyj has not paid the recourse claim to Inission Ab despite its request. The loan arrangement...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.